That makes physician supervision, side-effect monitoring, medication legitimacy, muscle preservation, and long-term maintenance even more important
Future research, including adequately powered subgroup analyses and real-world evidence, may help to further elucidate potential sex-related differences in clinical outcomes and economic value
The team from the University of Pennsylvania Health System noted that regulators in the US have been informed of the link between the drugs and hair loss, particularly for semaglutide (Wegovy and Ozempic) and tirzepatide (Mounjaro)
The FDA prescribing information does not mandate dose reduction before discontinuation, and there is no official evidence of withdrawal syndrome or rebound effects requiring gradual weaning
Product details and prices were reviewed on July 2, 2026
Gold-doxorubicin nanoconjugates for overcoming multidrug resistance